Investec advised the owners of Klinik für Hämatologie und Onkologie Hirslanden Zürich and of Onkozentrum Zürich on the majority sale to the owner family of Hirslanden.
About the deal
Investec acted as the exclusive financial advisor to Klinik für Hämatologie und Onkologie Hirslanden Zürich and Onkozentrum Zürich on their combined majority sale to the owner family of Hirslanden Group.
The two leading Swiss cancer care institutions offer together the complete range of services in oncology and hematology including highly specialized and most advanced diagnostic and treatment options. With a team of ca. 20 highly experienced medical oncologists (many of them international key opinion leaders in their field), over 11’000 therapies are performed annually at five locations in the canton of Zurich for all cancer types.
Hirslanden is the largest private clinic group in Switzerland with 17 hospitals, many of which have an emergency department. It also operates 5 outpatient surgery centres, 19 radiology and 6 radiotherapy institutes. The Group has 2’651 partner doctors and 11’146 employees.
The strategic partnership between the oncology centers and Hirslanden will allow for high-quality medical care while focusing on entrepreneurial continuity: as co-shareholders the doctor-owners will continue to ensure the medical and entrepreneurial success of their centres.
“”
“The collaboration with the M&A-Team of Investec was very positive. The team prepared and executed the project with high professionalism and efficiency, supporting both companies’ shareholders with great commitment in all project phases. Thanks to their expertise, manpower and result-oriented approach, also in complex situations, we could realize an ideal transaction result with a strategically highly relevant partner. We greatly appreciated the personal and professional collaboration with Investec.”
Our role
The Investec team advised the owners of the two oncology centers throughout the entire M&A process until the successful completion of the transaction, including:
- Preparation of business plan and marketing materials,
- Detailed analysis of Tardoc impact (Swiss healthcare reimbursement system),
- Identification of potential buyers (strategic and financial),
- Market approach and realization of a competitive sales process,
- Preparation and management of due diligence,
- Conducting price negotiations,
- Support in negotiations of the legal documentation,
- Coordination of all involved parties, incl. legal and tax advisors.
